Clinical Trials in Arizona

Showing 8301-8320 of 14,395 trials

Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease

NCT04118985

The Researchers are trying to better understand if behavioral interventions can help improve memory compensation and engagement in healthy lifestyle behaviors in those with memory concerns but normal mental status exam.

Cognitive SymptomPre Senile DementiaAlzheimer Disease

Mayo Clinic21 participantsStarted Oct 2019

Scottsdale, Arizona, United States

WITHDRAWNPhase 231 miles

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

NCT04138485

This randomized, multicenter, double-blind (DB), placebo controlled, phase 2 study will evaluate the efficacy and safety of IgPro10. The DB Treatment Period will be followed by a 24-week Open-label (OL) Treatment Period. Eligible subjects will be randomized at Baseline in a 2:1 ratio of treatment IgPro10 or placebo in the DB Treatment Period. All subjects who enter OL Treatment Period will receive IgPro10.

Diffuse Cutaneous Systemic Sclerosis

CSL BehringStarted Dec 2019

Scottsdale, Arizona, United States • Los Angeles, California, United States • Los Angeles, California, United States +74 more locations

Compensatory Training to Support Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Find Trials by Condition in Arizona

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

Bone Mineral Density in Women With Uterine Fibroids or Endometriosis

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Spinal Cord Stimulation With Precision® System Versus Reoperation for Failed Back Surgery Syndrome

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Quality of Life in Patients With Congenital Afibrinogenemia

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

GreenLight XPS Laser System Retrospective Chart Review

Safety and Tolerability Study for Age-Related Macular Degeneration

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).